Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion type Assertion NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_head.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion description "[Preclinical studies have demonstrated single-agent antitumor activity of GEM 231 in a variety of human cancer xenograft models, and additive or synergistic antitumor activity has been observed with taxane and/or camptothecin-based combinations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_provenance.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion evidence source_evidence_literature NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_provenance.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion SIO_000772 14751840 NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_provenance.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion wasDerivedFrom befree-20150227 NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_provenance.
- NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_assertion wasGeneratedBy ECO_0000203 NP422661.RAl8D-b-SbrDSLHVIT-vbGDUCa0ksNAZfojeEIXFSJQ8o130_provenance.